Name: 세계 유방 재건 시장 - 2023-2030 - Prime research
SKU: DMMD6133
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 유방 재건 시장 규모는 2022년 YY백만 달러였으며, 2030년까지 YY백만 달러에 이를 것으로 예상되며, 예측 기간(2023-2030년) 동안 연평균 성장률(CAGR)은 YY%입니다.
유방 재건은 완전히 새로운 유방 모양 또는 형태를 만드는 수술 과정입니다. 유방 절제술(유방 전체를 제거하는 수술로, 경우에 따라 림프절과 근육도 함께 제거됨) 또는 유방 보존술(유방의 일부만 제거하는 수술) 후에 시행될 수 있습니다. 유방 재건은 주로 유방의 대칭을 회복하기 위해 시행됩니다. 유방 재건을 받을지 여부는 환자의 생활 방식, 전반적인 건강 상태, 암 치료 상태, 체형 등 여러 변수에 따라 결정됩니다.
시장 동향
유방암 환자 증가, 유리한 의료비 상환 정책, 기술 발전, 유방 재건 시술 증가 등이 예측 기간 동안 시장 성장을 견인할 요인입니다.
전 세계적으로 유방암 발병률이 증가하는 추세가 시장 성장을 촉진할 것으로 예상됩니다.

유방 재건술은 유방의 모양과 형태를 복원하는 수술입니다. 유방암 수술을 받은 여성도 이 시술을 받을 수 있습니다. 또한, 보형물, 자가 조직 또는 이 둘을 조합하여 자연스러운 유방을 재건하는 것을 목표로 합니다. 세계보건기구(WHO)는 2020년 전 세계적으로 230만 명의 여성이 유방암 진단을 받았으며, 이로 인해 68만 5천 명이 사망했다고 추산합니다. 또한, 지난 5년간 유방암 진단을 받은 780만 명의 여성이 2020년에도 생존해 있었으며, 이는 유방암이 전 세계적으로 가장 흔한 암 중 하나임을 보여줍니다.
더불어, 미국 질병통제예방센터(CDC)에 따르면 미국에서는 매년 약 2,300명의 남성과 25만 5천 명의 여성이 유방암 진단을 받습니다. 미국 성형외과학회는 310만 명 이상의 미국인이 유방암을 성공적으로 극복했다고 보고합니다. 따라서 전 세계적으로 유방 재건술에 대한 수요가 증가하고 있습니다. 따라서 위의 요인들로 인해 시장은 예측 기간 동안 성장세를 보일 것으로 예상됩니다.
하지만 유방 수술 비용이 높은 점은 시장 성장을 저해할 것으로 예상됩니다.
유방 재건 수술은 일반적으로 한쪽 유방당 25,000달러에서 50,000달러 이상, 양쪽 유방 모두 재건하는 경우 50,000달러에서 100,000달러의 비용이 소요됩니다. 또한, 유방조영술, 토모신테시스, 제로유방조영술, 유즙조영술, 유방 MRI, 신티맘모그래피, 탄성초음파, 유방 생검 등 유방암 조기 진단을 위한 다양한 영상 검사법의 개발로 유방 재건 수술을 받는 경우가 줄어들어 시장 성장을 제한할 것으로 예상됩니다.

COVID-19 영향 분석
코로나19 팬데믹은 전 세계 성형외과 업계에 큰 변화를 가져왔습니다. 팬데믹 기간 동안 병원들은 미국 외과의사협회의 COVID-19 수술 분류 지침을 준수하며 수술 건수를 엄격하게 제한했습니다. 유방암 환자들은 유방 재건을 위해 외래 성형외과로 의뢰되기도 했고, 자가 조직 재건, 보형물 재건, 유두-유륜 재건을 포함한 유방 재건 수술을 외래 성형외과에서 기다리고 있다가 연기된 환자들도 있었습니다. 예를 들어, 일본외과학회에 따르면 이 기간 동안 유방암 수술 대상자는 56명이었습니다. 2020년 4월 1일부터 4월 19일까지 예정된 유방암 수술 17건은 수술실 사용 제한의 영향을 받지 않았습니다. 2020년 4월 20일부터 6월 31일까지는 유방암 수술 39건이 예정되었으나, 26건(66.7%)은 긴급성이 낮거나 중간 정도라는 이유로 취소되었습니다. 같은 기간 동안 유방 재건 수술은 41건이 예정되어 있었습니다. 17명의 환자는 유방 재건이 필요했지만 해당 기간 동안 수술 일정이 잡히지 않았습니다. 이처럼 위와 같은 요인들로 인해 시장에 영향이 미쳤습니다. 하지만 향후 전망 기간 동안 상황은 점차 개선될 것으로 예상됩니다.

시장 분석
유방 재건 시장에서 임플란트 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
임플란트 부문은 2021년에도 가장 큰 시장 점유율을 기록했습니다. 유방암 발병률 및 유방 재건 수술 건수 증가, 실리콘 및 식염수 유방 임플란트 수요 증가가 이 부문의 성장을 견인하고 있으며, 신제품 출시 및 FDA 승인 증가 또한 향후 시장 성장을 촉진할 요인입니다. 예를 들어, GC Aesthetics, Inc.(GCA)는 차세대 유방 임플란트인 PERLE을 출시했습니다. PERLE은 독자적인 표면 기술(BioQ), GCA의 업계 최고 수준 젤 기술(Emunomic Breast Tissue Dynamic Gel), 그리고 GCA의 오랜 안전 기록을 뒷받침해 온 안전 기능의 강화된 버전을 포함하는 혁신적인 매끄러운 유방 임플란트 라인입니다. 이 새로운 제품 라인은 GCA의 40년 이상 축적된 업계 경험, 환자 안전 및 혁신에 대한 장기적인 노력, 그리고 탁월한 고객 서비스 및 지원을 바탕으로 외과의와 환자에게 더욱 향상된 매끄러운 임플란트를 제공합니다. 따라서 위의 요인들을 종합해 볼 때, 해당 시장 부문은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
지역 분석
북미 지역은 전 세계 유방 재건 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미 지역은 2021년에도 가장 큰 시장 점유율을 기록했습니다. 유방암 발병률 증가, 시장 참여자들의 신제품 출시, 유방 보형물 기술 발전, FDA 승인, 그리고 유방 재건에 대한 인식 제고 등이 예측 기간 동안 이 지역의 성장을 견인하는 요인입니다. 예를 들어, breast cancer.org에서 발표한 자료에 따르면, 2022년 미국에서는 약 287,857건의 새로운 침습성 유방암 사례와 51,400건의 새로운 비침습성 유방암 사례가 여성에게서 진단될 것으로 예상됩니다. 또한, 같은 해 남성에게서는 약 2,710건의 새로운 침습성 유방암 사례가 진단될 것으로 추정됩니다.

또한, 유방 재건 인식 캠페인은 미국 성형외과학회(ASPS)와 성형외과 재단(PSF)의 후원을 받으며, 기업, 기관, 개인 병원 및 개인의 재정적 지원을 받고 있습니다. 이 캠페인의 목표는 유방암 진단 후 여성들이 최선의 결정을 내릴 수 있도록 교육하고, 참여를 유도하며, 역량을 강화하는 것입니다. 여기에는 여성, 가족, 간병인 및 언론에 여성이 유방 재건 옵션에 대해 알게 될 때까지 유방암 치료 과정이 계속될 것이라는 사실을 알리는 것이 포함됩니다. 이 캠페인은 다각적인 접근 방식을 취하며 광범위한 대중 홍보 활동을 포함합니다. 전국 및 지역 행사, 프로그램, 그리고 기존 및 새로운 미디어를 결합한 노력을 통해 수백만 명의 사람들이 유방 절제술 후 유방 재건 옵션에 대한 정보를 얻었습니다. 따라서 위의 요인들을 고려할 때, 이 시장은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
경쟁 환경
유방 재건 시장의 주요 업체로는 Allergan Plc, Sientra, Inc., IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A., GC Aesthetics, Groupe Sebbin SAS, Ideal Implant Incorporated, Laboratoires Arion 및 Mentor Worldwide LLC가 있습니다.
2021년 5월 25일, GC Aesthetics는 독자적인 표면 기술을 적용한 혁신적인 차세대 유방 보형물인 PERLE을 출시했습니다.
Allergan Plc:
개요:
Allergan Plc는 브랜드 의약품, 바이오시밀러 및 일반의약품(OTC)을 개발 및 판매하는 전문 제약 회사인 AbbVie Inc.의 자회사입니다. 안과, 피부과, 위장관, 중추신경계, 여성 건강, 비뇨기과 및 항감염 치료제 분야에서 제품을 제공합니다. 이 회사는 소매업체, 의약품 도매업체, 유통업체, 통신판매업체, 병원, 진료소, 정부 기관, 건강 관리 기관(HMO)과 같은 관리형 의료 서비스 제공업체 및 기타 조직에 제품을 판매합니다. 미주, 유럽, 아시아 태평양, 중동 및 아프리카 전역에 걸쳐 사업망을 구축하고 있습니다.
제품 포트폴리오:
나트렐 유방 보형물: 알러간의 나트렐 실리콘 충전 유방 보형물은 실리콘 외피에 실리콘 젤이 채워져 있습니다. 다양한 크기로 제공되며, 외피 표면은 매끄러운 것과 질감이 있는 것 두 가지 종류가 있습니다. 22세 이상 여성의 유방 확대 수술과 모든 연령대의 여성의 유방 재건 수술에 사용이 승인되었습니다.
글로벌 유방 재건 시장 보고서는 약 45개 이상의 시장 데이터 표, 40개 이상의 그림, 180페이지 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Market Overview
The global breast reconstruction market size was valued US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period (2023-2030).
Breast reconstruction is a surgical process in which an entirely new breast shape or mound is produced. It can be done either following a mastectomy (where the entire breast is removed, occasionally along with the associated lymph nodes and muscles) or following breast conservation (where only parts of the breast are removed). Breast reconstruction is frequently carried out to restore the symmetry of the breasts. The decision to undergo breast reconstruction will depend on many variables, including the patient's lifestyle, general health, cancer treatment status, and body type.
Market Dynamics
The rise in breast cancer patients and the availability of favorable reimbursement policies, technological advancements and an increase in breast reconstruction procedures are the factors to drive the market in the forecast period.
The increasing prevalence of breast cancer worldwide is expected to drive market growth.
Breast reconstruction is a surgical procedure that restores the breast's appearance and shape. Women who have previously undergone breast cancer surgeries can get it done. It also promotes using prosthetic implants, autologous tissue, or a combination of both to reconstruct a breast that looks natural. WHO (World Health Organization) estimates that 2.3 million women received breast cancer diagnoses globally in 2020, contributing to 6,85,000 fatalities. Additionally, 7.8 million women diagnosed with breast cancer over the previous five years were still alive in 2020, making it one of the most common cancers worldwide.
Furthermore, 2300 men and about 255,000 women in the United States are diagnosed with breast cancer each year, according to the CDC (Centers for Disease Control and Prevention). The American Society of Plastic Surgeons reports that more than 3.1 million Americans have successfully battled breast cancer. Therefore, it has increased the demand for breast reconstruction worldwide. Thus, from the above factors, the market is expected to drive in the forecast period.
The high cost of breast surgical procedures is expected to hamper the market growth.
Breast reconstruction surgery typically costs between USD 25,000 and USD 50,000, or even more, per breast and between USD 50,000 and USD 100,000 for both breasts. Furthermore, the development of various image detection tests for early stages of breast cancer, such as Mammography, Tomosynthesis, Xeromammography, Galactography, Breast MRI, Scintimammography, Elastography, Breast biopsy, and so on, will reduce the likelihood of undergoing surgical procedures for breast reconstruction, thereby restricting the overall market growth.
COVID-19 Impact Analysis
The coronavirus disease 2019 (COVID-19) pandemic dramatically changed the landscape of plastic surgery across the globe. During the pandemic, hospitals strictly limited the number of surgical cases by following the American College of Surgeons' COVID-19 surgical triage guidelines. Patients with breast cancer were also referred from outpatient to outpatient plastic surgery clinics for breast reconstruction, and those waiting for breast reconstruction (including autologous tissue reconstruction, implant reconstruction, and nipple-areola reconstruction) at an outpatient plastic surgery clinic who are postponed. For instance, According to the Japan Surgical Society, 56 patients were candidates for breast cancer surgery during this period. The OR restrictions did not affect seventeen breast cancer surgeries scheduled between April 1 and April 19, 2020. From April 20 to June 31, 2020, 39 breast cancer surgeries were scheduled, but 26 (66.7%) were canceled due to a lack of urgency (medium or low). During this time, 41 breast reconstruction surgeries were scheduled. Seventeen more patients had breast reconstruction but did not have surgery scheduled during the time frame. Thus, from the above factors, the market got affected. However, the situation is expected to improve gradually in the forecast period.
Segment Analysis
Implants segment is expected to hold the largest market share in breast reconstruction market
The implants segment accounted for the largest market share in 2021. The segment is benefiting due to the increasing prevalence of breast cancer cases & breast reconstruction procedures and the increase in demand for silicone & saline breast implants; increasing product launches and FDA approvals are the factors to drive the market segment in the forecast period. For instance, GC Aesthetics, Inc. (GCA) launched its next generation of breast implants, PERLE. PERLE is a highly innovative line of smooth breast implants that includes a proprietary surface technology (BioQ), GCA's industry-leading gel technology (Emunomic Breast Tissue Dynamic Gel), and an enhanced version of the safety features that have underpinned GCA's long-term excellent safety record. The new product line offers surgeons and patients an advanced line of smooth implants that benefit from GCA's over 40 years in the industry, a long-term focus on patient safety and innovation, and exceptional customer service and support. Thus, from the above factors, the market segment accounted for the largest market share in the forecast period.
Geographical Analysis
North America region holds the largest market share in the global breast reconstruction market
North America region accounted for the largest market share in 2021. The increasing prevalence of breast cancer, product launches by the market players, advancement in breast implants, FDA approvals of the products, and rising awareness of breast reconstruction among people are the factors to drive the region's growth in the forecast period. For instance, according to data published by breast cancer.org, approximately 287,857 new invasive breast cancer cases and 51,400 new non-invasive breast cancer cases will be diagnosed in women in the United States in 2022. In addition, nearly 2,710 new invasive breast cancers were estimated to be diagnosed in men in the same year.
Furthermore, the Breast Reconstruction Awareness Campaign is sponsored by the American Society of Plastic Surgeons (ASPS) and The Plastic Surgery Foundation (PSF), and corporations, institutions, private practices, and individuals financially support it. Its goal is to educate, engage, and empower women to make the best decisions after a breast cancer diagnosis. This includes informing women, family members, caregivers, and the media that the breast cancer loop will remain open until a woman learns about breast reconstruction options. The campaign is multifaceted and includes extensive public communication efforts. Millions of people have been informed about breast reconstruction options following mastectomy through national and local events, programming, and a combination of traditional and new media efforts. Thus, from the above factors, the market is expected to hold the largest market share in the forecast period.
Competitive Landscape
Major key players in the breast reconstruction market are Allergan Plc, Sientra, Inc., IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A., GC Aesthetics, Groupe Sebbin SAS, Ideal Implant Incorporated, Laboratoires Arion and Mentor Worldwide LLC
On May 25, 2021, GC Aesthetics launched its next-generation breast implants, PERLE, a highly innovative line of smooth breast implants with a proprietary surface technology.
Allergan Plc:
Overview:
Allergan Plc. is a subsidiary of AbbVie Inc, a specialty pharmaceutical company that creates and markets branded, biosimilar, and over-the-counter (OTC) medications. It offers products in the fields of ophthalmology, dermatology, gastrointestinal, central nervous system, women's health, urology, and anti-infective therapeutics. The company sells its product to retailers, drug wholesalers, distributors, mail-order businesses, hospitals, clinics, government entities, managed healthcare providers like health maintenance organizations, and other organizations. It has processes across the Americas, Europe, Asia-Pacific, the Middle East, and Africa.
Product Portfolio:
Natrelle Breast Implants: Allergan's Natrelle Silicone-Filled Breast Implants have a silicone outer shell filled with silicone gel. They come in different sizes and have either smooth or textured shells. They are approved for breast augmentation in women age 22 or older and breast reconstruction in women of any age.
The global breast reconstruction market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing prevalence of breast cancer worldwide is expected to drive market growth.
4.1.2. Restraints:
4.1.2.1. The high cost of breast surgical procedures is expected to hamper the market growth.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces
5.2. Supply Chain
5.3. Pricing Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Implants*
7.2.1.1. Saline Implants
7.2.1.2. Introduction
7.2.1.3. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.2.1.4. Silicone Implants
7.3. Tissue Expander
7.4. Acellular Dermal Matrix
8. By Shape
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
8.1.2. Market Attractiveness Index, By Shape
8.2. Round Shape*
8.2.1.1. Introduction
8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Anatomical Shape
9. By Placement
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
9.1.2. Market Attractiveness Index, By Placement
9.2. Dual Plane Insertion*
9.2.1.1. Introduction
9.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Subglandular Insertion
9.4. Submuscular Insertion
10. By End user
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.1.2. Market Attractiveness Index, By End user
10.2. Hospitals*
10.2.1.1. Introduction
10.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Ambulatory Surgical Centers
10.4. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Allergan Plc*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Sientra, Inc
13.3. IDEAL IMPLANT INCORPORATED
13.4. Johnson & Johnson
13.5. Establishment Labs S.A.
13.6. GC Aesthetics
13.7. Groupe Sebbin SAS
13.8. Ideal Implant Incorporated
13.9. Laboratoires Arion
13.10. Mentor Worldwide LLC
LIST NOT EXHAUSTIVE
14. Global Breast Reconstruction Market– DataM
14.1. Appendix
14.2. About Us and Applications
14.3. Contact Us

언급된 주요 기업들

Allergan Plc, Sientra, Inc, IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A., GC Aesthetics, Groupe Sebbin SAS, Ideal Implant Incorporated, Laboratoires Arion, Mentor Worldwide LLC

표 목록 (Tables)

List of Tables

Table 1 Global Breast Reconstruction Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Breast Reconstruction Market Value, By Shape, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Breast Reconstruction Market Value, By Placement, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Breast Reconstruction Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Breast Reconstruction Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Breast Reconstruction Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 8 Global Breast Reconstruction Market Value, By Shape, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 10 Global Breast Reconstruction Market Value, By Placement, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 12 Global Breast Reconstruction Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 14 Global Breast Reconstruction Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Breast Reconstruction Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 17 North America Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 18 North America Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 19 North America Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 20 North America Breast Reconstruction Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 22 South America Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 23 South America Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 24 South America Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 25 South America Breast Reconstruction Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 27 Europe Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 28 Europe Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 29 Europe Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 30 Europe Breast Reconstruction Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Breast Reconstruction Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 40 Allergan Plc: Overview

Table 41 Allergan Plc: Product Portfolio

Table 42 Allergan Plc: Key Developments

Table 43 Sientra, Inc: Overview

Table 44 Sientra, Inc: Product Portfolio

Table 45 Sientra, Inc: Key Developments

Table 46 IDEAL IMPLANT INCORPORATED: Overview

Table 47 IDEAL IMPLANT INCORPORATED: Product Portfolio

Table 48 IDEAL IMPLANT INCORPORATED: Key Developments

Table 49 Johnson & Johnson: Overview

Table 50 Johnson & Johnson: Product Portfolio

Table 51 Johnson & Johnson: Key Developments

Table 52 Establishment Labs S.A.: Overview

Table 53 Establishment Labs S.A.: Product Portfolio

Table 54 Establishment Labs S.A.: Key Developments

Table 55 GC Aesthetics: Overview

Table 56 GC Aesthetics: Product Portfolio

Table 57 GC Aesthetics: Key Developments

Table 58 Groupe Sebbin SAS: Overview

Table 59 Groupe Sebbin SAS: Product Portfolio

Table 60 Groupe Sebbin SAS: Key Developments

Table 61 Ideal Implant Incorporated: Overview

Table 62 Ideal Implant Incorporated: Product Portfolio

Table 63 Ideal Implant Incorporated: Key Developments

Table 64 Laboratoires Arion: Overview

Table 65 Laboratoires Arion: Product Portfolio

Table 66 Laboratoires Arion: Key Developments

Table 67 Mentor Worldwide LLC: Overview

Table 68 Mentor Worldwide LLC: Product Portfolio

Table 69 Mentor Worldwide LLC: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 2 Global Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 4 Global Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 5 Global Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 6 Global Breast Reconstruction Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Breast Reconstruction Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 8 Implants Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 9 Tissue Expander Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 10 Acellular Dermal Matrix Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 11 Global Breast Reconstruction Market Y-o-Y Growth, By Shape, 2022-2030 (%)

Figure 12 Round Shape in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 13 Anatomical Shape in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 14 Global Breast Reconstruction Market Y-o-Y Growth, By Placement, 2022-2030 (%)

Figure 15 Dual Plane Insertion Placement in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 16 Subglandular Insertion Placement in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 17 Submuscular Insertion Placement in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 18 Global Breast Reconstruction Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 19 Hospitals End User in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 20 Ambulatory Surgical Centers End User in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 21 Others End User in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 22 Global Breast Reconstruction Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 23 North America Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 24 Asia-Pacific Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 25 Europe Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 26 South America Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 27 Middle East and Africa Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 28 North America Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 29 North America Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 30 North America Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 31 North America Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 32 North America Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 33 North America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 34 North America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 35 North America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 36 North America Breast Reconstruction Market Share, By Country, 2022 & 2030 (%)

Figure 37 South America Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 38 South America Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 39 South America Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 40 South America Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 41 South America Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 42 South America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 43 South America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 44 South America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 45 South America Breast Reconstruction Market Share, By Country, 2022 & 2030 (%)

Figure 46 Europe Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 47 Europe Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 48 Europe Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 49 Europe Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 50 Europe Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 51 Europe Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 52 Europe Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 53 Europe Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 54 Europe Breast Reconstruction Market Share, By Country, 2022 & 2030 (%)

Figure 55 Asia-Pacific Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 56 Asia-Pacific Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 57 Asia-Pacific Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 58 Asia-Pacific Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 59 Asia-Pacific Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 60 Asia-Pacific Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 61 Asia-Pacific Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 62 Asia-Pacific Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 63 Asia-Pacific Breast Reconstruction Market Share, By Country, 2022 & 2030 (%)

Figure 64 Middle East & Africa Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 65 Middle East & Africa Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 66 Middle East & Africa Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 67 Middle East & Africa Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 68 Middle East & Africa Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 69 Middle East & Africa Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 70 Middle East & Africa Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 71 Middle East & Africa Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 72 Allergan Plc: Financials

Figure 73 Sientra, Inc: Financials

Figure 74 IDEAL IMPLANT INCORPORATED: Financials

Figure 75 Johnson & Johnson: Financials

Figure 76 Establishment Labs S.A.: Financials

Figure 77 GC Aesthetics: Financials

Figure 78 Groupe Sebbin SAS: Financials

Figure 79 Ideal Implant Incorporated: Financials

Figure 80 Laboratoires Arion: Financials

Figure 81 Mentor Worldwide LLC: Financials

세계 유방 재건 시장 – 2023-2030

Global Breast Reconstruction Market - 2023-2030